A Study to Evaluate the Immunogenicity and Safety of SCTV01C and SCTV01E (Two Recombinant Protein COVID-19 Vaccines) in Population Aged ≥12 Years

NCT05308602 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped There was not a need any more.

Conditions

COVID-19
SARS-CoV-2 Infection

Interventions

BIOLOGICAL: SCTV01C
BIOLOGICAL: SCTV01C
BIOLOGICAL: SCTV01C
BIOLOGICAL: SCTV01E
BIOLOGICAL: SCTV01E
BIOLOGICAL: SCTV01E
BIOLOGICAL: mRNA vaccine manufactured by Pfizer or Moderna
BIOLOGICAL: mRNA vaccine manufactured by Pfizer or Moderna
BIOLOGICAL: mRNA vaccine manufactured by Pfizer or Moderna
BIOLOGICAL: Sinopharm inactivated COVID-19 vaccine
BIOLOGICAL: Sinopharm inactivated COVID-19 vaccine
BIOLOGICAL: Sinopharm inactivated COVID-19 vaccine

Sponsor

Sinocelltech Ltd.